Advertisement

Latest News

FDA Approves Vadadustat (Vafseo) Tablets for Anemia Due to CKD in Adult Patients on Dialysis

8 hours ago

Vadadustat tablets are now approved for the treatment of anemia due to CKD in adults who have been receiving dialysis for ≥ 3 months.

Tildrakizumab Significantly Improves Skin Symptoms in Moderate-to-Severe Psoriasis

9 hours ago

At week 52, investigators noted an overall improvement of 93% in PASI scores from baseline.

Allogenic HSCT May Improve Sickle Cell Disease-Related Organ Dysfunction

11 hours ago

A new analysis summarized evidence on the effects of allogeneic HSCT on SCD-related organ dysfunction in pediatric and adult patients with SCD.

Novel CAR-T Cell Therapy Trial for Lupus Launched by Atlantic Health System

12 hours ago

Mohamed Cherry, MD, and Neil Kramer, MD, shed light on a phase 1 trial using CAR-T cell therapy for SLE and its potential implications for lupus treatment.

Vadadustat Response Influenced by Patient Background in Anemia from CKD

14 hours ago

A posthoc analysis of two phase 3 trials identified multiple independent factors associated with better response to vadadustat in patients with anemia.

Advertisement
Advertisement